Publication dates

All regions

Clinical Trial Industry, October 2014 Market Reports from Top Publishers

You might be interested in: drug, medical equipment, therapeutics, more »


 
1-20 of about 3 100 reports for Clinical Trial

Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China:  From Regulations to Practices (2014 Edition)

Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)

  • $ 1 495
  • Industry report
  • October 2014
  • by Access China Management Consulting Ltd.

Executive Summary China's regulatory framework for medical devices is undergoing radical changes. The country's new leaders have recognized that the regulations for supervision and administration of medical ...

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... clinical trial supply, clinical technologies and commercial services. Almac has operations in the us (california, north carolina and pennsylvania) and asia (singapore and japan) and is headquartered ...

Hadasit Bio-Holdings Ltd. (Symbol:HDST) SWOT Analysis, Strategy, Revenues and Profits

Hadasit Bio-Holdings Ltd. (Symbol:HDST) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... For phase ii by the portfolio companies. Hadasit's preparations include pre-clinical trials, manufacturing, regulatory and business development tasks. The company's portfolio of companies includes prot ...

PAION AG (Symbol:PA8) SWOT Analysis, Strategy, Revenues and Profits

PAION AG (Symbol:PA8) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Thrombotic diseases, blood vessel related diseases and central nervous system disorders. The company also offers phase-iii clinical trials for the cure of anesthesia and procedural sedation, and phase ...

ChemDiv, Inc. SWOT Analysis, Strategy, Revenues and Profits

ChemDiv, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Services to the research, medical, pharmaceutical, veterinary and biotechnology industries. Its services include cord blood, clinical trial services, atcc, archival, cryobyte, and adult stem cell storage ...

Linical Co., Ltd. (Symbol:2183) SWOT Analysis, Strategy, Revenues and Profits

Linical Co., Ltd. (Symbol:2183) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Execution status; among others. Lincal's quality control services comprise adjusting clinical trial standard business procedure sheets with the pharmaceutical companies; confirming quality control policies ...

Southern Research Institute SWOT Analysis, Strategy, Revenues and Profits

Southern Research Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And clinical trial support services for pharmaceutical and biotechnology companies. The company offers wide range of engineering services in the areas of advanced materials and structures; airborne sensor design ...

ReSearch Pharmaceutical Services, Inc. - Strategic SWOT Analysis Review

ReSearch Pharmaceutical Services, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary ReSearch Pharmaceutical Services, Inc. (RPS) is a contract research organization. The company provides phase I-IV clinical development services to pharmaceutical, biotechnology and medical device ...

OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, ...

About 5 500 reports for Clinical Trial

Download Unlimited Documents from Trusted Public Sources

Clinical Trial Industry in the US

  • Nci Clinical Trials Portfolio Inventory Fy 2011
  • July 2013
    25 pages
  • Clinical Trial  

  • United States  

View report >

77 Companies for Clinical Trial

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.